SCHEMBL22774740

SCHEMBL22774740

CCc1nc(C(=O)OC)c(CC)s1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.57
NPSR1 Q6W5P4 1/20 0.47
ALDH1A1 P00352 6/20 0.36
HSD17B10 Q99714 5/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
PKM P14618 3/20 0.34
ATM Q13315 1/20 0.34
TSHR P16473 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 1/20 0.33
RAB9A P51151 2/20 0.33
RAF1 P04049 1/20 0.33
FBP1 P09467 1/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1548833 0.82 L3MBTL1 (0.57) L3MBTL1NPSR1ALDH1A1HSD17B10KDM4E
SCHEMBL4852589 0.82 NPSR1 (0.47) L3MBTL1NPSR1ALDH1A1HSD17B10KDM4E
SCHEMBL7944932 0.81 NPSR1 (0.45) L3MBTL1NPSR1ALDH1A1HSD17B10KDM4E
SCHEMBL535765 0.81 L3MBTL1 (0.56) L3MBTL1NPSR1ALDH1A1HSD17B10KDM4E
SCHEMBL535799 0.81 L3MBTL1 (0.56) L3MBTL1NPSR1ALDH1A1HSD17B10KDM4E
SCHEMBL22774382 0.79 L3MBTL1 (0.40) L3MBTL1ALDH1A1KMT2ARAB9AFBP1
SCHEMBL27275301 0.78 L3MBTL1 (0.36) L3MBTL1NPSR1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL28397369 0.73 L3MBTL1 (0.43) L3MBTL1ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL6430358 0.72 L3MBTL1 (0.41) L3MBTL1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL18003085 0.72 L3MBTL1 (0.78) L3MBTL1NPSR1ALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624023-B2 Sulfonylurea derivatives and uses thereof NodThera Limited (GB) 2026-05-12 US disclosed
EP-3983407-B1 SULFONYLUREA DERIVATIVES AND USES THEREOF NODTHERA LTD (GB) 2025-11-12 EP disclosed
CN-114222739-B Sulfonylurea derivatives and their use 诺瑟拉有限公司 2025-02-11 CN disclosed
US-20230083495-A1 SULFONYLUREA DERIVATIVES AND USES THEREOF NodThera Limited (GB) 2023-03-16 US disclosed
EP-3983407-A1 SULFONYLUREA DERIVATIVES AND USES THEREOF Nodthera Limited (GB) 2022-04-20 EP disclosed
CN-114222739-A Sulfonylurea derivatives and use thereof 诺瑟拉有限公司 2022-03-22 CN disclosed
WO-2020249664-A1 SULFONYLUREA DERIVATIVES AND USES THEREOF NodThera Limited (GB) 2020-12-17 WO disclosed
WO-2020249664-A1 SULFONYLUREA DERIVATIVES AND USES THEREOF NodThera Limited (GB) 2020-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624023-B2 Sulfonylurea derivatives and uses thereof PYCARD, NOD1, NLRP3 L3MBTL1 3947/4885NPSR1 3941/4885ALDH1A1 561/4885
US-20230083495-A1 SULFONYLUREA DERIVATIVES AND USES THEREOF IL1B, NOD1, IL1A L3MBTL1 4161/4885NPSR1 3296/4885ALDH1A1 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.